ATE279413T1 - Pyrazolobenzodiazepine mit cdk2 hemmender wirkung - Google Patents

Pyrazolobenzodiazepine mit cdk2 hemmender wirkung

Info

Publication number
ATE279413T1
ATE279413T1 AT00929360T AT00929360T ATE279413T1 AT E279413 T1 ATE279413 T1 AT E279413T1 AT 00929360 T AT00929360 T AT 00929360T AT 00929360 T AT00929360 T AT 00929360T AT E279413 T1 ATE279413 T1 AT E279413T1
Authority
AT
Austria
Prior art keywords
pyrazolobenzodiazepines
inhibiting effect
cdk2
cdk2 inhibiting
effect
Prior art date
Application number
AT00929360T
Other languages
English (en)
Inventor
Qingjie Ding
Jin-Jun Liu
Vincent Stewart Madison
Giacomo Pizzolato
Chung-Chen Wei
Peter Michael Wovkulich
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE279413T1 publication Critical patent/ATE279413T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/22Sulfur atoms
AT00929360T 1999-04-21 2000-04-14 Pyrazolobenzodiazepine mit cdk2 hemmender wirkung ATE279413T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13037099P 1999-04-21 1999-04-21
PCT/EP2000/003394 WO2000064900A1 (en) 1999-04-21 2000-04-14 Pyrazolobenzodiazepines as cdk2 inhibitors

Publications (1)

Publication Number Publication Date
ATE279413T1 true ATE279413T1 (de) 2004-10-15

Family

ID=22444382

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00929360T ATE279413T1 (de) 1999-04-21 2000-04-14 Pyrazolobenzodiazepine mit cdk2 hemmender wirkung

Country Status (33)

Country Link
US (3) US6440959B1 (de)
EP (1) EP1185529B1 (de)
JP (1) JP3746680B2 (de)
KR (1) KR100481757B1 (de)
CN (2) CN1196703C (de)
AR (1) AR023542A1 (de)
AT (1) ATE279413T1 (de)
AU (1) AU768667B2 (de)
BR (1) BR0009887A (de)
CA (1) CA2367704C (de)
CO (1) CO5170444A1 (de)
CZ (1) CZ20013738A3 (de)
DE (1) DE60014893T2 (de)
DK (1) DK1185529T3 (de)
ES (1) ES2228522T3 (de)
HK (1) HK1046278B (de)
HR (1) HRP20010742A2 (de)
HU (1) HUP0300318A3 (de)
IL (1) IL145764A0 (de)
JO (1) JO2248B1 (de)
MA (1) MA26782A1 (de)
NO (1) NO20015065D0 (de)
NZ (1) NZ514523A (de)
PE (1) PE20010054A1 (de)
PL (1) PL200933B1 (de)
PT (1) PT1185529E (de)
RU (1) RU2249593C2 (de)
SI (1) SI1185529T1 (de)
TR (1) TR200103016T2 (de)
TW (1) TW585866B (de)
WO (1) WO2000064900A1 (de)
YU (1) YU73101A (de)
ZA (1) ZA200108016B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4497921B2 (ja) * 2001-11-13 2010-07-07 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 置換1,4−ベンゾジアゼピンおよび癌の処置のためのその使用
FR2847253B1 (fr) * 2002-11-19 2007-05-18 Aventis Pharma Sa Nouveaux derives de pyridazinones a titre de medicaments et compositions pharmaceutiques les renfermant
JP2006519236A (ja) * 2003-02-27 2006-08-24 アボット・ラボラトリーズ 複素環式キナーゼ阻害剤
DE602005007623D1 (de) * 2004-10-13 2008-07-31 Hoffmann La Roche Als cdk2- und angiogenese-inhibitoren und für die behandlung von brust-, kolon-, lungen- und prostatakrebs geeignete disubstituierte pyrazolobenzodiazepine
AU2006301292A1 (en) * 2005-10-14 2007-04-19 F. Hoffmann-La Roche Ag Regimen of administration for 5-(2-chlorophenyl)-1 ,2-dihydro-7-fluoro-8-methoxy-3-methyl-pyrazolo (3, 4.-b) (1, 4) benzodiazepine
PT2081921E (pt) 2006-07-10 2010-12-10 Paion Uk Ltd Sais de benzodiazepina de acção curta e suas formas polimórficas
KR20100073454A (ko) * 2008-12-23 2010-07-01 국립암센터 트란스글루타미나제 억제제로 사용되는 신규한 피라졸로디아제핀계 화합물, 이의 제조방법 및 이를 포함하는 조성물
EP2305647A1 (de) 2009-09-18 2011-04-06 PAION UK Limited Verfahren zur Herstellung von 3-[(4S)-8-brom-1-methyl-6-(2-pyridinyl)-4 H-imidazo[1,2-a][1,4]benzodiazepin-4-yl]propionsäuremethylester oder das Benzensulfonatsalz davon und in diesem Prozess nützliche Verbindungen
EP2450039A1 (de) 2010-11-08 2012-05-09 PAION UK Ltd. Dosierschema zur Sedierung mit CNS 7056 (Remimazolam)
SG11201404596UA (en) * 2012-02-02 2014-10-30 Senex Biotechnology Inc Cdk8/cdk19 selective inhibitors and their use in anti-metastatic and chemopreventative methods for cancer
CN103288828A (zh) * 2012-02-24 2013-09-11 中国科学院大连化学物理研究所 一种合成手性二氢-6H-吲哚并[2,1-c][1,4]-苯并二氮杂卓的方法
CN102603743B (zh) * 2012-02-24 2014-05-28 南京天易生物科技有限公司 抗肿瘤的氮杂苯并[f]薁衍生物其制备方法及其用途
CN103288830A (zh) * 2012-02-24 2013-09-11 中国科学院大连化学物理研究所 一种合成手性二氢-5H-吡咯并[2,1-c][1,4]-苯并二氮杂卓的方法
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión
CN106608877B (zh) * 2015-10-21 2018-11-13 新发药业有限公司 一种依鲁替尼中间体4-氨基-3-(4-苯氧基)苯基-1H-吡唑并[3,4-d]嘧啶的制备方法
EP3535253A1 (de) * 2016-11-01 2019-09-11 H. Hoffnabb-La Roche Ag 1,3-dihydro-1,4-benzodiazepin-2-thione zur behandlung von zns-bedingten erkrankungen
EP3447056A4 (de) 2016-12-13 2019-09-18 Nanjing Transthera Biosciences Co. Ltd. Mehrfachkinasehemmerverbindung, kristallform und verwendung davon
CN109020980B (zh) * 2017-06-09 2020-11-20 华东师范大学 一类抗肿瘤作用的吡唑并嘧啶二氮*衍生物
US11066404B2 (en) 2018-10-11 2021-07-20 Incyte Corporation Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
WO2020168197A1 (en) 2019-02-15 2020-08-20 Incyte Corporation Pyrrolo[2,3-d]pyrimidinone compounds as cdk2 inhibitors
TW202100520A (zh) 2019-03-05 2021-01-01 美商英塞特公司 作為cdk2 抑制劑之吡唑基嘧啶基胺化合物
US11919904B2 (en) 2019-03-29 2024-03-05 Incyte Corporation Sulfonylamide compounds as CDK2 inhibitors
US11447494B2 (en) 2019-05-01 2022-09-20 Incyte Corporation Tricyclic amine compounds as CDK2 inhibitors
US11440914B2 (en) 2019-05-01 2022-09-13 Incyte Corporation Tricyclic amine compounds as CDK2 inhibitors
MX2022001940A (es) 2019-08-14 2022-05-10 Incyte Corp Compuestos de imidazolil pirimidinilamina como inhibidores de cdk2.
PE20221905A1 (es) 2019-10-11 2022-12-23 Incyte Corp Aminas biciclicas como inhibidoras de la cdk2
EP4148054A1 (de) * 2020-05-08 2023-03-15 Transthera Sciences (Nanjing), Inc. Syntheseverfahren für antitumorverbindung und zwischenprodukt davon
WO2022113003A1 (en) 2020-11-27 2022-06-02 Rhizen Pharmaceuticals Ag Cdk inhibitors
WO2022149057A1 (en) 2021-01-05 2022-07-14 Rhizen Pharmaceuticals Ag Cdk inhibitors
WO2022237765A1 (zh) * 2021-05-10 2022-11-17 药捷安康(南京)科技股份有限公司 多激酶抑制剂的药物组合物及其用途
US11976073B2 (en) 2021-12-10 2024-05-07 Incyte Corporation Bicyclic amines as CDK2 inhibitors
WO2024030399A2 (en) * 2022-08-02 2024-02-08 Lab1636, Llc Use of a gaba-a pam for reduction of tactile hypersensitivity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998014450A1 (en) 1996-10-02 1998-04-09 Novartis Ag Pyrimidine derivatives and processes for the preparation thereof
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers

Also Published As

Publication number Publication date
DE60014893T2 (de) 2005-10-13
CA2367704A1 (en) 2000-11-02
PE20010054A1 (es) 2001-02-07
KR100481757B1 (ko) 2005-04-11
HUP0300318A3 (en) 2004-11-29
CN1196703C (zh) 2005-04-13
HRP20010742A2 (en) 2002-12-31
NO20015065L (no) 2001-10-18
US20020183514A1 (en) 2002-12-05
ES2228522T3 (es) 2005-04-16
KR20010112435A (ko) 2001-12-20
AU4748000A (en) 2000-11-10
HK1046278B (zh) 2005-08-12
AR023542A1 (es) 2002-09-04
US6838558B2 (en) 2005-01-04
JP3746680B2 (ja) 2006-02-15
CA2367704C (en) 2008-06-17
CZ20013738A3 (cs) 2002-08-14
MA26782A1 (fr) 2004-12-20
DE60014893D1 (de) 2004-11-18
NO20015065D0 (no) 2001-10-18
PL354405A1 (en) 2004-01-12
IL145764A0 (en) 2002-07-25
ZA200108016B (en) 2003-03-26
BR0009887A (pt) 2002-01-22
CO5170444A1 (es) 2002-06-27
EP1185529B1 (de) 2004-10-13
RU2249593C2 (ru) 2005-04-10
TW585866B (en) 2004-05-01
PL200933B1 (pl) 2009-02-27
JP2002543081A (ja) 2002-12-17
HK1046278A1 (en) 2003-01-03
US6916923B2 (en) 2005-07-12
YU73101A (sh) 2004-05-12
CN1603314A (zh) 2005-04-06
US6440959B1 (en) 2002-08-27
TR200103016T2 (tr) 2002-04-22
WO2000064900A1 (en) 2000-11-02
US20040198976A1 (en) 2004-10-07
HUP0300318A2 (hu) 2003-06-28
EP1185529A1 (de) 2002-03-13
JO2248B1 (en) 2004-10-07
SI1185529T1 (en) 2005-02-28
AU768667B2 (en) 2003-12-18
NZ514523A (en) 2003-11-28
CN1279029C (zh) 2006-10-11
PT1185529E (pt) 2005-02-28
DK1185529T3 (da) 2005-02-07
CN1348455A (zh) 2002-05-08

Similar Documents

Publication Publication Date Title
ATE279413T1 (de) Pyrazolobenzodiazepine mit cdk2 hemmender wirkung
DE60044873D1 (de) Orientierte biopolymermembrane
DE60036160D1 (de) Elektroentionisierungsvorrichtung
PT1341791E (pt) Imidazoquinolinas substituidas com tioeter
DE10084662T1 (de) Mehrfachbahn-Verbinden
DE60025791D1 (de) Ellipsometer
NO20005446L (no) Organiske artikler
DE19983871T1 (de) Fönvorrichtung
DE10084676T1 (de) Einmallanzettvorrichtung
ATA51899A (de) Handstempel
ATE357433T1 (de) 4-pyrimidinyl-n-acyl-l-phenylanine
DE60040557D1 (de) Elektrolumineszierendes element
DE50000494D1 (de) Funktionsträgeranordnung
ATE297895T1 (de) 4-pyridinyl-n-acyl-l-phenylalanine
ATE519761T1 (de) 5-aminoalkyl-pyrazoloä4,3-düpyrimidine mit phosphodiesterase v inhibierender wirkung
DE29903989U1 (de) Zielfernrohr
NO20004717L (no) Sikkerhetskile-lukkehode
DE60143148D1 (de) En mit honigwaben
DE50000805D1 (de) Aufsitzspanner
DE60025370D1 (de) 9a-azalide mit antibakterieller wirkung
DE60024023D1 (de) Nockenwellenversteller
DE69933927D1 (de) Absoluter wertkodierer
DE60034087D1 (de) Farbeditiersystem
DE19983890T1 (de) Ventiltaktgebungsjustiereinrichtung
ID25567A (id) Ulir-jepit dengan bahu-puntir

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1185529

Country of ref document: EP